Definium Therapeutics, Inc. Announces Pricing of $700 Million Upsized Public Offering
Definium Therapeutics priced an upsized public offering of 20,588,236 shares at $34.00 per share, generating expected gross proceeds of approximately $700 million. The company plans to use the net proceeds to fund research and development, preparation for potential commercialization of DT120 ODT, and general corporate purposes. J.P.
Key figures
- Deal Value Usd
- 700000000
- Offering Price
- 34
- Shares Offered
- 20588236
- Greenshoe shares
- 3088235
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.